Skip to content

Case Study

Pharmaceutical Manufacturer

Leading the Way in Sustainability and Social Responsibility in the Construction Industry

Leading Pharmaceutical Manufacturer Avoids Multi-Million Exposure

A global pharmaceutical company manufactures one of its blockbuster vaccines in a 365,000 sq. ft. New York facility. This aged and leaky facility posed a severe threat to the sold-out capacity, which, if shut down, would cost them over $42 million dollars in production losses, clean-up costs, business interruption, fines, and lost market share. One of their options included shutting down the facility and relocating the production to an off-shore site. RAM Companies was hired to develop objective options.

Single-Source Solutions

RAM Companies' solution roadmap started with aerial and hand-held infrared thermography to identify and quantify the extent of the hidden moisture damage. This data complemented the physical roof and wall surveys to achieve a comprehensive list of prioritized recommendations and budgets. The best option was to preserve the building and implement an aggressive restoration/replacement program.

Our design and engineering teams developed detailed specifications that helped bring the project under budget estimates due to “apples-to-apples” bids. The projects were more complex due to the winter install, elevated roof work, and very tight staging parameters. RAM’s project management and quality control teams covered multiple simultaneous reroofing and wall restoration projects requiring three full-time supervisors on the roof and inside the plant.

One Phone Call to Make

The successful installation was done on time and under budget. The Client only wanted “One Phone Call to Make” or one company to take full responsibility. RAM Companies' collaborative approach included Design/Build services and our 15-year warranty and maintenance inspection program.


Pharma Manufacturer

Sites Scanned


Sites Scanned


Project Type

Diagnostic Roof Assessments

Cost Savings


Related Projects